Publicaciones (99) Publicaciones de Tomás H González Hernández

2024

  1. Analysis of Random Lasing in Human Blood

    Biosensors, Vol. 14, Núm. 9

2023

  1. Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation

    Molecular Therapy - Methods and Clinical Development, Vol. 31

2022

  1. Random lasing as a sensing tool in brain samples of an animal model of Huntington's disease

    Applied Physics Letters, Vol. 121, Núm. 12

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Novel Random Laser-based probe of Huntington Disease in cell cultures

    Progress in Biomedical Optics and Imaging - Proceedings of SPIE

  3. Novel random laser-based probe of Huntington disease in cell cultures

    Optics InfoBase Conference Papers

  4. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism

    Pharmacological Research, Vol. 165

2020

  1. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

    Autophagy, Vol. 16, Núm. 7, pp. 1279-1295

2019

  1. Random lasing in brain tissues

    Organic Electronics, Vol. 75

2018

  1. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

    Experimental Neurology, Vol. 299, pp. 137-147

2016

  1. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

    Molecular Therapy - Methods and Clinical Development, Vol. 3, pp. 16027

  2. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system

    Neurobiology of Disease, Vol. 88, pp. 44-54

2015

  1. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake

    Neurobiology of Disease, Vol. 74, pp. 325-335

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2013

  1. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein

    Histology and Histopathology, Vol. 28, Núm. 8, pp. 999-1006

  2. The neuronal serum- and glucocorticoid-regulated kinase 1.1 reduces neuronal excitability and protects against seizures through upregulation of the M-current

    Journal of Neuroscience, Vol. 33, Núm. 6, pp. 2684-2696

2012

  1. Differential N termini in epithelial Na + channel δ-subunit isoforms modulate channel trafficking to the membrane

    American Journal of Physiology - Cell Physiology, Vol. 302, Núm. 6

  2. Neonatal apneic seizure of occipital lobe origin: Continuous video-EEG recording

    Pediatrics, Vol. 129, Núm. 6

2010

  1. The dopamine transporter is differentially regulated after dopaminergic lesion

    Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530

  2. The neuronal-specific SGK1.1 kinase regulates δ-epithelial Na + channel independently of PY motifs and couples it to phospholipase C signaling

    American Journal of Physiology - Cell Physiology, Vol. 299, Núm. 4